Table 1. Kaplan-meier analyses for prognosis and survival rate of 154 CRC patients.

	Frequency	MST	95% CI		Survival rate		χ2	P-value
			Lower	Upper	3 years	5 years
Gender
Male	84	26.400±4.308	17.957	34.843	34.50%	13.50%	2.559	0.11
Female	70	23.000±2.353	18.388	27.612	24.30%	1.40%
Age (years)
≤60	69	25.400±3.322	18.888	31.912	33.30%	8.20%	0.005	0.945
>60	85	24.600±3.022	18.677	30.523	27.10%	7.50%
Location
Colon	50	20.900±2.576	15.851	25.949	32.00%	6.00%	1.638	0.201
Rectum	104	27.000±2.719	21.67	32.33	28.80%	8.60%
Size
≤5 cm	93	28.600±3.154	22.417	34.783	34.40%	9.80%	3.721	0.054
>5 cm	61	20.800±2.789	15.334	26.266	23.00%	4.90%
Histological type
Adenocarcinoma	132	25.400±2.503	20.494	30.306	31.10%	8.30%	0.792	0.373
Other	22	20.800±3.694	13.56	28.04	22.70%	4.50%
Differentiation
High	52	31.900±2.404	27.189	36.611	38.50%	15.40%	12.936	0.002
Moderate	88	22.500±2.345	17.903	27.097	27.30%	2.00%
Low	14	10.300±4.677	1.133	19.467	14.00%	0.00%
T stage
T2+T3	113	26.400±2.780	20.951	31.849	33.60%	7.80%	2.615	0.106
T4	41	21.400±3.265	15.001	27.799	19.50%	7.30%
N stage
N0	56	28.600±6.174	16.499	40.701	44.60%	15.60%	10.912	0.004
N1	52	21.400±2.644	16.218	26.582	21.20%	5.80%
N2	46	24.600±5.143	14.519	34.681	21.70%	0.00%
TNM
Stage II	56	28.600±6.174	16.499	40.701	44.60%	15.60%	10.461	0.001
Stage III	98	22.500±2.772	17.067	27.933	21.40%	3.30%
hTERT
Low	33	32.700±13.781	5.69	59.71	48.50%	18.20%	8.867	0.003
High	121	23.700±2.369	19.056	28.344	24.80%	5.00%
KRT23
Low	41	34.100±2.048	30.085	38.115	43.90%	18.20%	8.895	0.003
High	113	21.900±2.050	17.882	25.918	24.80%	4.00%
h(TERT)/K(RT23)
h low/K high	22	22.100±6.039	10.264	33.936	41.00%	13.60%	17.836	0.000
h low/K low	11	46.500±13.322	20.39	72.61	63.60%	27.30%
h high/K low	30	32.600±2.876	26.964	38.236	36.70%	15.00%
h high/K high	91	21.400±1.828	17.817	24.983	20.90%	1.60%

The bold and italic means P-value<0.05.